Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

Ghent-based Dualyx Raises €40m to Progress Treg Therapies (2023-05-15)
> Use of proceeds will enable the development of the Company’s lead autoimmune program DT-001, targeting TNFR2, as well as its pipeline of Treg candidates > Financing co-led by Fountain Healthcare Partners, Forbion and Andera Partners with support from existing ...
DiogenX Raises €27.5M Series A Led by BIVF & RVF (2023-05-10)
> Series A – led by Boehringer Ingelheim Venture Fund and Roche Venture Fund – to fund novel beta cell regeneration approach > Lead program has the potential to become the first disease-modifying treatment against symptomatic type 1 diabetes DiogenX, a biot...
Transgene: New CEO & AstraZeneca Terminates Collaboration (2023-05-05)
> Current Chairman, Dr Alessandro Riva, MD, to become Chairman and Chief Executive Officer – Hedi Ben Brahim to retire as CEO. > Decision made by AstraZeneca to terminate the oncolytic virus R&D collaboration. > Transgene remains focused on its strategic prio...
Alia Therapeutics Appoints Letizia Goretti as CEO (2023-05-05)
Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, announced the appointment of Letizia Goretti as Chief Executive Officer (CEO) and Board Director, effective i...
Evommune Closes $50m Series B, Co-led by Arix Bioscience (2023-04-26)
> Financing co-led by Arix Bioscience, EQT Life Sciences and SymBiosis, with participation from new and existing investors including Amplitude Ventures, and Series A leads Pivotal bioVenture Partners and Andera Partners > Capital on-hand provides strong financia...
Ariceum Expands Series A by €22.75m to Total of €47.75m (2023-04-18)
> New investors, Andera Partners and Earlybird Venture Capital, join existing investor, Pureos Bioventures raising an additional EUR 22.75 million > Funds will be used to advance clinical pipeline and further build Ariceum Therapeutics > Olivier Litzka from A...
Alia Therapeutics: €4.4m Seed Extension Led by Sofinnova (2023-04-17)
Funding to accelerate development of innovative CRISPR-based therapies Alia Therapeutics, a Trento-based start-up specializing in innovative treatments for rare genetic diseases through next-generation gene editing technology, has secured a €4.4 million seed ...
Alentis’ $105m Series C Led by Jeito with Novo & RA Capital (2023-04-13)
Proceeds will fund: > Clinical programs ALE.F02 and ALE.C04 – two first-in-class anti-Claudin-1 (CLDN1) antibodies for organ fibrosis and CLDN1 positive tumors > The platform to engineer CLDN1 antibody drug conjugates (ADC) and bispecific antibodies Alen...
Calida Therapeutics Starts with €2m Seed Funding form AdBio (2023-04-06)
> Newly created biotech will leverage US research work from Cleveland, Ohio to develop monoclonal antibodies to treat and prevent thrombo-inflammatory disorders > Company is initially funded by AdBio partners with €2M and appoints Clément Bertholet as CEO C...
Pierre Fabre Licenses Two Cancer Drugs from Scorpion Tx (2023-04-04)
— Scorpion receives $65 million from an upfront payment and the achievement of near-term milestones and is eligible to receive up to $553 million in potential milestones, plus royalties on net product sales – — Scorpion will retain rights to STX-721 and STX-241 ...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)